- Home
- HTCR vs ECOR Comparison
HTCR vs ECOR Comparison
Compare HTCR & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTCR
- ECOR
- Stock Information
- Founded
- HTCR 2009
- ECOR 2005
- Country
- HTCR Japan
- ECOR United States
- Employees
- HTCR N/A
- ECOR N/A
- Industry
- HTCR EDP Services
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HTCR Technology
- ECOR Health Care
- Exchange
- HTCR Nasdaq
- ECOR Nasdaq
- Market Cap
- HTCR 48.1M
- ECOR 57.5M
- IPO Year
- HTCR 2022
- ECOR 2018
- Fundamental
- Price
- HTCR $0.84
- ECOR $6.45
- Analyst Decision
- HTCR
- ECOR Strong Buy
- Analyst Count
- HTCR 0
- ECOR 2
- Target Price
- HTCR N/A
- ECOR $25.50
- AVG Volume (30 Days)
- HTCR 87.3K
- ECOR 216.9K
- Earning Date
- HTCR 05-13-2025
- ECOR 03-12-2025
- Dividend Yield
- HTCR 4.67%
- ECOR N/A
- EPS Growth
- HTCR N/A
- ECOR N/A
- EPS
- HTCR 0.23
- ECOR N/A
- Revenue
- HTCR $30,290,930.00
- ECOR $25,182,000.00
- Revenue This Year
- HTCR $53.30
- ECOR $40.88
- Revenue Next Year
- HTCR N/A
- ECOR $48.01
- P/E Ratio
- HTCR $3.69
- ECOR N/A
- Revenue Growth
- HTCR 47.63
- ECOR 57.09
- 52 Week Low
- HTCR $0.55
- ECOR $5.32
- 52 Week High
- HTCR $3.38
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- HTCR 40.92
- ECOR 15.95
- Support Level
- HTCR $0.95
- ECOR $6.57
- Resistance Level
- HTCR $1.10
- ECOR $8.25
- Average True Range (ATR)
- HTCR 0.09
- ECOR 0.90
- MACD
- HTCR 0.01
- ECOR -0.23
- Stochastic Oscillator
- HTCR 42.86
- ECOR 1.56
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company. It provides software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. The customer experience management platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, its DX division, is a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.